oseltamivir has been researched along with Dengue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonzi, DS; Barnard, D; Biggins, J; Caputo, AT; Duchars, M; Dwek, RA; Hill, JC; Kiappes, JL; Roversi, P; Sheets, N; Shresta, S; Treston, AM; Warfield, KL; Zitzmann, N | 1 |
| Alisjahbana, B; de Mast, Q; Gasem, MH; Kuntjoro, L; Nugraha, HG; Pramudo, SG; Riswari, SF; Tunjungputri, RN; van der Ven, A | 1 |
1 trial(s) available for oseltamivir and Dengue
| Article | Year |
|---|---|
Effect of oseltamivir phosphate versus placebo on platelet recovery and plasma leakage in adults with dengue and thrombocytopenia; a phase 2, multicenter, double-blind, randomized trial.
Topics: Adolescent; Adult; Antiviral Agents; Blood Platelets; Dengue; Double-Blind Method; Female; Humans; Male; Oseltamivir; Young Adult | 2022 |
1 other study(ies) available for oseltamivir and Dengue
| Article | Year |
|---|---|
Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
Topics: alpha-Glucosidases; Animals; Dengue; Dengue Virus; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glycoside Hydrolase Inhibitors; Humans; Influenza, Human; Mice, 129 Strain; Mice, Inbred BALB C; Protein Structure, Secondary | 2020 |